Accessory Reagents
Showing all 20 results
CD16a/Fcgr3A, C-terminal Avi-HIS-tag, in vivo biotinylated
Soluble CD16A/Fcgr3a, C-terminally HIS-Avi-tagged, produced in HEK293 cells and in vivo mono-biotinylated. Recombinant FcγRs can be used to monitor immune processes, providing a time-efficient and reproducible alternative to laborious cell-based assays.
CD16b/Fcgr3b, C-terminal Avi-HIS-tag, in vivo biotinylated
Soluble 3CD16b/Fcgr3b, C-terminally HIS-Avi-tagged, produced in HEK293 cells and in vivo mono-biotinylated. This product can be applied in multiplex assays to characterise IgG subclass-specific affinities supporting research into immune therapies, including therapeutic antibodies and novel vaccines.
CD32A/Fcgr2a, C-terminal Avi-HIS-tag, in vivo biotinylated
Soluble CD32A/Fcgr2a, C-terminally HIS-Avi-tagged, produced in HEK293 cells and in vivo mono-biotinylated. This product can be applied in multiplex assays to characterise IgG subclass-specific affinities supporting research into immune therapies, including therapeutic antibodies and novel vaccines.
CD32B/Fcgr2b, C-terminal Avi-HIS-tag, in vivo biotinylated
Recombinant human soluble CD32B/Fcgr2b, C-terminally HIS-Avi-tagged, produced in HEK293 cells and in vivo mono-biotinylated. This product can be applied in multiplex assays to characterise IgG subclass-specific affinities supporting research into immune therapies, including therapeutic antibodies and novel vaccines.
Human Chorionic Gonadotropin Hormone (subunit alpha+beta), Recombinant
Human chorionic gonadotropin hormone, subunits alpha and Beta, produced in HEK293 cells and purified by affinity chromatography and dialysis.
Human Follicle-stimulating Hormone (subunit alpha+beta), Recombinant
Human follicle-stimulating hormone (FSH), subunit Alpha+Beta, produced in HEK293 cells and purified by affinity chromatography and dialysis.
Human Prolactin Hormone, Recombinant
Human prolactin hormone, produced in HEK293 cells with a C-terminal His-tag / 2x Strep-tag and purified by affinity chromatography and dialysis.
Human Sex Hormone – binding globulin, Recombinant
Human sex hormone-binding globulin (SHBG) expressed in HEK293 cells with Strep II / His-tag and purified on a Strep-tactin column by affinity chromatography, followed by anion exchange chromatography.
Human Thyrotropin Hormone, Recombinant
Human Thyrotropin hormone, or thyroid-stimulating hormone (TSH), produced in HEK293 cells and purified by affinity chromatography and dialysis.
Japanese Encephalitis Virus Vaccine Serum: 6-Month (IgG) Bleed
Liquid preparation of serum obtained from a recipient of the Japanese Encephalitis Virus vaccine (IXIARO (Strain SA14)), 6 months post immunisation.
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed
Liquid preparation of serum obtained from a recipient of Japanese Encephalitis vaccine, prior to their immunisation.
Recombinant Autographa Californica Multiple Nucleopolyhedrovirus, Lysate
Recombinant Autographa californica multiple nucleopolyhedrovirus (ACMNPV) particles, containing GFP expression cassette. Baculovirus particles are lysed and inactivated for use as a control when testing baculovirus-insect cell derived material for vaccine and immunoassay development.
Recombinant Human IgE (kappa L), His-Tag
Recombinant human IgE (kappa L) protein is composed of the human Ɛ heavy chain and the Ƙ light chain. The heavy chain is C-terminally His-tagged. For use as a standard in assays or as a control antibody.
Recombinant Human IgE-Fc Domain
Recombinant human IgE-Fc domain, a human immunoglobulin epsilon heavy chain constant region (IgE-Fc), manufactured in mammalian cells. Recommended as an immunogen to generate antibodies against human anti-IgE-Fc, a standard/control for human IgE-Fc assays or other human IgE-Fc domain applications.
Yellow Fever Virus Vaccine Serum: 12-Month (IgG) Bleed
Yellow Fever Virus donor serum obtained from a recipient of Yellow Fever vaccine (17D strain), 12 months post immunisation.
Yellow Fever Virus Vaccine Serum: 2-Week (IgM) Bleed
Unique panel of Yellow Fever Virus donor serum, from a panel of donors immunised with the Yellow Fever vaccine, Stamaril. Samples are available from each donor prior to vaccination, and at 2-week and 6-week time points, to allow for assessment of IgM and IgG responses across broad response profiles. See donor selection table for donor details and travel history.
Yellow Fever Virus Vaccine Serum: 6-Month (IgG) Bleed
Yellow Fever Virus donor serum obtained from a recipient of Yellow Fever vaccine (17D strain), 6 months post immunisation.
Yellow Fever Virus Vaccine Serum: 6-Week (IgG) Bleed
unique panel of Yellow Fever Virus donor serum, from a panel of donors immunised with the Yellow Fever vaccine, Stamaril. Samples are available from each donor prior to vaccination, and at 2-week and 6-week time points, to allow for assessment of IgM and IgG responses across broad response profiles. See donor selection table for donor details and travel history.
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed
Yellow Fever Virus Donor Serum from pre-vaccination bleed. See donor selection table for donor details and travel history.
Yellow Fever Virus Vaccine Serum: Vaccination Time-Course Panel
Yellow Fever Virus Vaccine Serum triple pack of samples from an individual who was immunised with the Yellow Fever vaccine Stamaril (17D strain). The first vial is a pre-bleed sample, taken one week before the immunisation. The second vial is an “IgM” vial, taken 2 weeks post immunisation. The third vial is an “IgG” vial taken 6 weeks post immunisation.
Powered by Bioz